Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,383 total articles
Intel's recent string of strategic wins - including a prominent role in the Terafab project - and accelerating momentum in Intel Foundry Services make a high-conviction, actionable long trade. Market validation from partners and improving technicals support a longer-term play while execution and capital intensity remain real risks. Entry $60.50, ta…
Genmab is a high-quality antibody therapeutics developer trading at $28.54 with an $18.1B market cap. Recent Phase 3 results for epcoritamab (PFS positive, OS non-significant), the acquisition of Merus' petosemtamab and a 4.99% stake from Orbis make the stock sensitive to a cluster of near-term binaries. I outline a mid-term (45 trading days) long …
Nasdaq's core marketplace and expanding fintech footprint are showing tangible organic momentum even as macro uncertainty pressures near-term volumes. The stock is trading below key moving averages, offers a 1.2% yield, generates roughly $2.0B in free cash flow and has a valuation that still leaves upside if pilots and product rollouts accelerate. …
Elemental Royalty (ELE) is a focused precious-metals royalty acquirer trading at a $1.26B market cap. The company owns uncapped royalties across producing and near-producing mines and recently monetized a Nordic unit while retaining a 1% NSR in the region. With gold price direction, an acquisitive mandate, and a lean team, ELE offers a tradeable lo…
<p>Amadeus' U.S. OTC listing has been under pressure recently, but the technical picture and a rising short burden suggest the down leg may be stabilizing. With MACD turning positive, price sitting just below key short-term averages and short interest elevated, there is a tradeable asymmetric setup: limited downside with a clear recovery path to pr…
ECARX’s acquisition of DreamSmart pushes the company deeper into in-car software and content monetization. The move can accelerate recurring revenue and OEM relationships, but it is capital-intensive and raises execution risk. We lay out a mid-term swing trade that buys the thesis while limiting downside exposure.
Oscar Health (OSCR) is a high-growth ACA marketplace insurer that has suffered a sharp share-price reset. With membership growth, 2026 guidance for $18.7-19.0B revenue and $250-450M in operating earnings, and bargain-like multiples (EV/Sales ~0.18, P/S ~0.38), the risk/reward favors a constructive long position. This trade targets a full re‑rating …
Volaris (VLRS) has the network and cost discipline of an ultra-low-cost carrier, but a renewed oil shock and recent revenue softness create a window to short the stock over the mid-term. Enter at $7.65, stop at $8.40, target $6.00 on a 45-trading-day horizon.
Helios (HLIO) has moved from distressed lows to a constructive technical and fundamental setup. With solid free cash flow, manageable leverage and improving technical momentum, the stock looks actionable on a disciplined entry. This trade idea lays out an exact entry, stop and target tied to support, moving averages and valuation context — but it a…
Broadcom just crossed an inflection point: a strategic Triad AI partnership (deal details limited publicly) materially strengthens its custom-ASIC and data-center networking moats. Valuation is rich but supported by large free cash flow, strong returns on equity, and improving technicals. This trade plan targets capitalizing on continued enterprise…
I increased my Tesla position at $342.34 because the setup combines an oversold technical base, meaningful free cash flow, low leverage and a near-term product roadmap that could reaccelerate volumes. Valuation is full, so this is a tactical, growth-with-drawdown trade sized for conviction but capped for risk.
Coca-Cola HBC (CCHGY) looks buyable around $58.45. The company mixes predictable beverage volume recovery across Europe with margin resilience and a dividend yield near 1.9%. With a market cap of roughly $21.3B, a P/E around 20 and constructive technicals, this is a medium-risk, long-term trade aimed at recapturing the 52-week high while collecting…
Microsoft looks like a candidate where the selloff is driven by macro uncertainty rather than company-specific deterioration. For traders willing to accept medium risk, a controlled long with a clear stop and a mid-term horizon capitalizes on likely mean reversion as fundamentals and AI-driven revenue durability reassert themselves.
Teradyne has quietly moved from a cyclical semiconductor-test play to a diversified supplier of AI infrastructure and automation. Strong AI-related demand, expanding robotics revenue, healthy cash flow and low leverage support a long-biased trade. Valuation is rich vs. history but justified by rapid revenue/margin expansion; trade with a clear stop…
TSMC is the dominant foundry behind the AI compute boom. With a $1.88 trillion market cap, strong technical momentum, and hyperscaler capex forecasts supporting demand, a disciplined long trade into weakness makes sense. Entry at $364, stop $345, target $420 over a 180-trading-day horizon balances upside from continued AI investment against valuati…
Cardinal Energy looks positioned to compound cash flow in 2026 even if oil drifts around $75/bbl. The company’s production profile, capital discipline and hedging cadence create a favorable risk-reward: a defined-entry trade can capture upside from higher cash returns, deleveraging and potential multiple expansion while keeping downside contained w…
General Motors is generating meaningful free cash flow and trading at attractive multiples versus its cash-generation profile. I raise my tactical target on GM and recommend a mid-term long entry near $76 with a $92 target and a $69 stop. The trade banks on steady FCF, resilient truck demand and EV momentum, while respecting execution and macro ris…
Denison Mines (DNN) is a development-stage uranium company centered on the Wheeler River and Athabasca Basin joint ventures. With a market cap near $3.14B, active 2026 drilling (Wheeler North and Russell Lake JV programs), constructive technical setup and a manageable capital structure, Denison offers an asymmetric trade: near-term exploration cata…
Alibaba is building agentic AI capabilities (Qwen / Accio Work / Wukong) that can operate as digital employees for enterprises. The market has focused on macro and regulatory noise and is underpricing the revenue and enterprise-engagement optionality from agentic deployments. Technicals and sentiment suggest a tactical long with defined risk-reward…
Rolls‑Royce (RYCEY) is showing improving commercial aerospace aftermarket activity, steady defense demand and growing relevance in small modular reactors (SMRs). Technicals and liquidity patterns favor a bounce toward the 52‑week high. I’m upgrading to a buy for a mid‑term trade: entry $17.10, stop $15.50, target $19.50 over ~45 trading days, with …
I upgrade Amazon to a buy and propose a mid-term long trade. AWS's AI tailwind, improving momentum indicators and a valuation that still looks reasonable at ~30x earnings justify a tactical entry at $225.47. Target $255 with a $210 stop; keep position size disciplined given recent FCF weakness and macro risks.
DISCO (DSCSY) reported Q4 above management guidance and the stock sits well below its 52-week high despite a market cap of about $44.2B and a forward-looking memory-market tailwind. This trade idea lays out a mid-term (45 trading days) buy with precise entry, stop and target, a rationale tied to semicap demand and technical setup, and a balanced li…
Powell Industries has gone from deep cyclicality to a leadership position in custom electrical systems, driven by a $1.6 billion backlog, expanding automation capabilities, and steady dividend hikes. The stock is at its 52-week high and shows bullish momentum, but valuation is rich versus history. This is a swing trade: initiate a cautious long wit…
Eli Lilly's market leadership in GLP-1 obesity therapies and an expanding immunology pipeline justify a tactical long. The shares trade at a premium (market cap ~$895B, P/E ~41.5) but generate strong free cash flow and superior ROE. I'll go long LLY at $940 with a $1,100 target and $880 stop, structured for a long-term (180 trading days) hold while…
Diebold Nixdorf (DBD) looks set to benefit from renewed investor attention tied to expected index inclusion and a steady operational recovery. With positive free cash flow, improving retail product sales, and an EV/EBITDA of 9, the risk/reward favors a tactical long over the next several months. Entry: $80.00, Target: $95.00, Stop: $72.00.
